A DNA controlled-release coating for gene transfer: Transfection in skeletal and cardiac muscle

被引:65
作者
Labhasetwar, V
Bonadio, J
Goldstein, S
Chen, WL
Levy, RJ
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmaceut Sci, Omaha, NE 68198 USA
[2] Univ Michigan, Ann Arbor, MI 48109 USA
[3] Childrens Hosp Philadelphia, Abramson Pediat Res Ctr, Philadelphia, PA 19104 USA
关键词
D O I
10.1021/js980077+
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In this paper we report a novel technique of DNA-polymer coating for gene transfer. A proprietary DNA polymer solution was used for thin-layer coating on a chromic gut suture as a model study. The coated sutures were characterized for physical properties such as coating thickness, mass of the DNA deposited on the suture, surface characteristics as determined by scanning electron microscopy, and in Vitro DNA release characteristics under simulated physiologic conditions. The in vivo gene transfection using DNA-coated sutures was demonstrated in rat skeletal muscle and in canine atrial myocardium. A heat-stable human placental alkaline phosphatase (AP) plasmid was used as a marker gene. Incisions of 1 to 1.5 cm were made in the rat skeletal muscles or the canine atrial myocardium. The sites were closed with either the DNA-coated sutures or control sutures. Two weeks after the surgery, the tissue samples adjacent to the suture lines were retrieved and analyzed for AP activity. The DNA-coated sutures demonstrated a sustained release of the DNA under in vitro conditions, with an similar to 84% cumulative DNA release occurring in 26 days. An agarose gel electrophoresis of the DNA samples released from the suture demonstrated two bands, with the tower band corresponding to the input DNA (supercoiled). It seems that there was a partial transformation of the DNA from a supercoiled to an open circular form due to the polymer coating. The tissue sites, which received the DNA-coated sutures, demonstrated a significantly higher AP activity compared with the tissue sites that received control sutures. In the rat studies, the mean AP activity (square root of cpm/mu g protein) was 43.6 +/- 3.3 vs 20.6 +/- 2.1 (p = 0.001) at the control sites. Similarly, in the canine studies, the AP activity was 73.6 +/- 7.4 Vs 21.6 +/- 1.4 (p = 0.0009) at the control sites. Thus, our studies demonstrated a successful gene transfer using our DNA-polymer coating technique. This technique could be useful for coating sutures used in Vascular and general surgery, and also for coating medical devices, such as stents, catheters, or orthopedic devices, to achieve a site-specific gene delivery.
引用
收藏
页码:1347 / 1350
页数:4
相关论文
共 46 条
  • [31] Gene therapy for ischemic heart disease
    Malosky, S
    Kolansky, DM
    [J]. CURRENT OPINION IN CARDIOLOGY, 1996, 11 (04) : 361 - 368
  • [32] GENE THERAPYS GROWING PAINS
    MARSHALL, E
    [J]. SCIENCE, 1995, 269 (5227) : 1050 - 1055
  • [33] Biologically erodable microsphere as potential oral drug delivery system
    Mathiowitz, E
    Jacob, JS
    Jong, YS
    Carino, GP
    Chickering, DE
    Chaturvedi, P
    Santos, CA
    Vijayaraghavan, K
    Montgomery, S
    Bassett, M
    Morrell, C
    [J]. NATURE, 1997, 386 (6623) : 410 - 414
  • [34] GENE-THERAPY AND GENETIC-DISEASES - REVISITING THE PROMISE
    MEYERS, AS
    [J]. HUMAN GENE THERAPY, 1994, 5 (10) : 1201 - 1202
  • [35] THE BASIC SCIENCE OF GENE-THERAPY
    MULLIGAN, RC
    [J]. SCIENCE, 1993, 260 (5110) : 926 - 932
  • [36] Polyvinyl derivatives as novel interactive polymers for controlled gene delivery to muscle
    Mumper, RJ
    Duguid, JG
    Anwer, K
    Barron, MK
    Nitta, H
    Rolland, AP
    [J]. PHARMACEUTICAL RESEARCH, 1996, 13 (05) : 701 - 709
  • [37] GENE-THERAPY FOR CARDIOVASCULAR-DISEASE
    NABEL, EG
    [J]. CIRCULATION, 1995, 91 (02) : 541 - 548
  • [38] Cancer and gene therapy
    SchmidtWolf, GD
    SchmidtWolf, IGH
    [J]. ANNALS OF HEMATOLOGY, 1996, 73 (05) : 207 - 218
  • [39] NONVIRAL APPROACHES TO GENE-THERAPY
    SCHOFIELD, JP
    CASKEY, CT
    [J]. BRITISH MEDICAL BULLETIN, 1995, 51 (01) : 56 - 71
  • [40] GETTING HUMAN GENE-THERAPY TO WORK
    STEWART, FM
    [J]. JOURNAL OF CELLULAR BIOCHEMISTRY, 1995, 58 (04) : 416 - 423